Ziprasidone-induced hyperprolactinemia

dc.authoridUnal, Suheyla/0000-0003-3266-6256
dc.authoridUnal, Suheyla/0000-0003-3266-6256
dc.authoridKarlıdağ, Rifat/0000-0002-3650-0774
dc.authoridHAMURCU, HAYRIYE DILEK/0000-0002-1456-2499
dc.authoridSelçuk, Engin Burak/0000-0001-8484-0223
dc.authorwosidkarlıdağ, rıfat/AAB-4255-2021
dc.authorwosidUnal, Suheyla/JVO-8367-2024
dc.authorwosidUnal, Suheyla/HJH-7559-2023
dc.authorwosidKarlıdağ, Rifat/AAB-4281-2021
dc.authorwosidHAMURCU, HAYRIYE DILEK/W-2621-2017
dc.authorwosidSelçuk, Engin Burak/AAR-7556-2020
dc.contributor.authorCitil, Dilek Yalvac
dc.contributor.authorSelcuk, Engin
dc.contributor.authorKarlidag, Rifat
dc.contributor.authorUnal, Sueheyla
dc.date.accessioned2024-08-04T20:30:42Z
dc.date.available2024-08-04T20:30:42Z
dc.date.issued2008
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.pnpbp.2007.12.022
dc.identifier.endpage906en_US
dc.identifier.issn0278-5846
dc.identifier.issn1878-4216
dc.identifier.issue3en_US
dc.identifier.pmid18276052en_US
dc.identifier.scopus2-s2.0-39849104813en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage905en_US
dc.identifier.urihttps://doi.org/10.1016/j.pnpbp.2007.12.022
dc.identifier.urihttps://hdl.handle.net/11616/94469
dc.identifier.volume32en_US
dc.identifier.wosWOS:000254690300048en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofProgress in Neuro-Psychopharmacology & Biological Psychiatryen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInduced Galactorrheaen_US
dc.subjectProlactin Levelsen_US
dc.subjectSchizophreniaen_US
dc.subjectAntipsychoticsen_US
dc.subjectMechanismen_US
dc.titleZiprasidone-induced hyperprolactinemiaen_US
dc.typeLetteren_US

Dosyalar